Do CBD Metabolites Show Up on Drug Tests? Guide

Short answer

No, standard drug tests do not look for CBD metabolites. Most urine, saliva, and hair panels screen for THC-COOH, the main metabolite of delta-9 THC. CBD breaks down into 7-hydroxy-CBD and 7-carboxy-CBD. Those compounds are not the target of a typical 5-panel or 10-panel drug test. A positive result usually means THC or a THC metabolite triggered the test, not CBD itself.

do cbd metabolites show up on drug tests

Why CBD metabolites usually stay off the report

Immunoassays use antibodies that bind to a specific molecule shape. The common THC immunoassay binds to THC-COOH. CBD metabolites have a different shape. At normal doses, that difference keeps them below the cutoff. Confirmatory testing with GC-MS or LC-MS/MS separates CBD from THC by mass and retention time. That step confirms the exact compound.

related article

When a CBD product can still cause a positive test

Three situations can lead to a positive result even when you use CBD only:

cannabis metabolites vs thc what is the difference

• Full-spectrum CBD contains THC. Repeated high doses can build THC-COOH above the cutoff.
• Some immunoassays cross-react with high levels of CBD metabolites, such as 7-carboxy-CBD. This is uncommon but documented.
• Labels can be wrong. A product sold as THC-free may contain THC, or a product may be mislabeled.

Prerequisites before you test

• Know the test type: 5-panel, 10-panel, or expanded panel.
• Know the cutoff: 50 ng/mL is common for initial THC immunoassay; 15 ng/mL for confirmatory GC-MS or LC-MS/MS.
• Know your CBD product: isolate, broad-spectrum, or full-spectrum.
• Keep product lab reports that show cannabinoid content.

How to lower your risk step by step

1. Read the product certificate of analysis. Check the total THC level. Choose a product with a THC result below 0.3% or labeled THC-free.
2. Pick CBD isolate if your drug test is imminent. Isolate has no THC and no other cannabinoids.
3. Track your daily CBD dose in milligrams. Higher doses raise the chance of cumulative THC exposure from full-spectrum products.
4. Stop full-spectrum CBD at least 5 to 7 days before a scheduled test if your dose is high.
5. Ask a clinician for a timeline based on your dose and body fat.
6. Keep your fluid intake normal before the test.
7. Ask the testing lab which panel it uses. Confirm whether the panel includes CBD or a broad cannabinoid screen.
8. Request a confirmatory test if you get a preliminary positive. LC-MS/MS can tell THC-COOH from CBD metabolites.

What to do after a positive screen

Ask for the confirmatory result. A preliminary immunoassay is not a final result. The confirmation report should list the exact analyte and its concentration. If the report lists THC-COOH, that points to THC exposure. If it lists 7-carboxy-CBD, that points to CBD. Share your product lab reports and dose history with the medical review officer.

Bottom line

CBD metabolites do not show up on a standard drug test. THC metabolites do. The risk comes from THC in the product or from cross-reactivity on a nonspecific screen. Use isolate, check lab reports, and ask for confirmatory testing when needed.